StockVS

Garden Stage Limited (GSIW) 股票分析

金融服务

Garden Stage Limited

$30.00

+$0.00 (+0.00%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Garden Stage Limited operates through its subsidiaries to provide a comprehensive suite of financial services within the Hong Kong market, specifically focusing on securities dealing, brokerage, underwriting, investment advisory, due diligence, referral, and asset management. The company functions within the broader Financial Services sector and the specialized Capital Markets industry, positioning itself as an intermediary facilitating capital formation and wealth management activities for clients. Its market capitalization stands at $25.44M, while its trailing twelve-month revenue totals $8.09M, though the available employee count is not disclosed in the provided data. These valuation and revenue figures indicate that Garden Stage Limited is a small-cap entity operating with a relatively modest revenue base compared to established global financial institutions, suggesting a niche or early-stage market position where scale is currently limited.

财务健康

The company reported a revenue of $8.09M for the trailing twelve months, yet it recorded a net income of $-7,537,693 and an EBITDA figure that is not available, revealing a significant divergence between top-line activity and bottom-line profitability. The substantial gap between the positive revenue and the deep negative net income indicates a highly fragile cost structure where operating expenses far exceed gross profits, resulting in an operating margin of -192.2% and a profit margin of -93.2%. While the gross margin sits at 5.3%, suggesting that the cost of goods sold consumes nearly 95% of revenue, the negative operating and profit margins confirm that overheads and selling, general, and administrative costs are unsustainable at current levels. Free cash flow is not available in the current dataset, which limits the ability to assess immediate liquidity generation from operations but highlights the reliance on existing cash reserves. The company holds $10.30M in cash against $140,745 in debt, resulting in a debt-to-equity ratio of 0.71, which suggests a balance sheet that is not heavily leveraged despite the earnings losses. The current ratio of 2.51 indicates that the company possesses 2.51 times more current assets than current liabilities, pointing to strong short-term liquidity coverage despite the ongoing operational losses. Return on Equity stands at -56.3% and Return on Assets at -31.4%, metrics that collectively reveal that management has not yet generated returns on the capital invested or utilized, reflecting the severe profitability challenges facing the business.

估值评估

Trailing twelve-month P/E ratio and forward P/E ratio are both not available due to the negative earnings profile, implying that traditional earnings-based valuation models cannot be applied and that the market is pricing the stock based on assets or sales multiples rather than profitability. The price-to-book ratio is recorded at 0.99, indicating that the market values the company at approximately equal to its book value, suggesting no significant premium over the net asset value despite the lack of current earnings. Price-to-sales ratio stands at 3.15, while EV/EBITDA is not available; these alternative metrics suggest that investors are valuing the firm primarily on its revenue generation capacity and asset base rather than cash flow or earnings power. The 52-week trading range spans from a low of $8.00 to a high of $358.00, placing the current stock price well below the 52-week high and indicating high volatility within the recent price window. Beta is measured at 2.48, a figure that signifies the stock exhibits price volatility more than double that of the broader market, meaning price movements will likely be amplified relative to general market swings.

Growth & Income

Revenue growth year-over-year surged by 414.6%, whereas earnings growth is not available due to the company's negative net income, indicating that the recent top-line expansion has not yet translated into profitability and that revenue growth is occurring without corresponding earnings improvement. The company does not pay dividends, evidenced by a dividend yield of N/A and a payout ratio of 0.0%, which means that any generated cash flow is theoretically available for reinvestment or retention rather than distribution to shareholders. This zero payout ratio is consistent with a firm in a loss-making phase that must conserve resources rather than distribute income, as the negative earnings growth and lack of positive net income make a sustainable dividend impossible. The overall growth and income profile is characterized by explosive revenue expansion coupled with significant losses and no dividend income, presenting a high-risk, high-volatility asset structure where capital appreciation potential is decoupled from current earnings performance.

同行比较

Garden Stage Limited (GSIW) 在资本市场行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Garden Stage Limited GSIW $42.37M N/A
Morgan Stanley MS $317.08B 18.2
The Goldman Sachs Group, Inc. GS $293.39B 18.1
The Charles Schwab Corporation SCHW $155.48B 17.8

资本市场行业平均市盈率为20.3倍。Garden Stage Limited的市盈率为N/A。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Garden Stage Limited

Garden Stage Limited, through its subsidiaries, provides financial services in Hong Kong. It offers securities dealing and brokerage services; underwriting and placing services; investment advisory services; due diligence services; introduction and referral services; and asset management services, such as account and fund management services. The company was incorporated in 2022 and is headquartered in Central, Hong Kong. Garden Stage Limited is a subsidiary of Oriental Moon Tree Limited.

公司简介以英文显示。

访问官网 →

关键指标

市值
$42.37M
市盈率
N/A
52周最高
$358.00
52周最低
$8.00
平均成交量
53.09K
Beta系数
4.25

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
Hong Kong